NATERA, INC. Financing Receivable, Allowance for Credit Loss, Writeoff
NATERA, INC. (NTRA) reported Financing Receivable, Allowance for Credit Loss, Writeoff of $53.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:FinancingReceivableAllowanceForCreditLossesWriteOffs · last filed 2026-08-07
- NATERA, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2026-06-30 was $53.00K, a 140.91% increase year-over-year.
- NATERA, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2026-03-31 was $313.00K, a 1465.00% increase year-over-year.
- NATERA, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was $30.00K, a 87.12% decline year-over-year.
- NATERA, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2025-06-30 was $22.00K, a 52.17% decline year-over-year.
- NATERA, INC. financing receivable, allowance for credit loss, writeoff for fiscal 2021 was $1.64M.
| Period end | Financing Receivable, Allowance for Credit Loss, Writeoff 3 month | Financing Receivable, Allowance for Credit Loss, Writeoff 6 month | Financing Receivable, Allowance for Credit Loss, Writeoff 9 month | Financing Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2026-06-30 | $53.00K 10-Q · filed 2026-08-07 | $366.00K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $313.00K 10-Q · filed 2026-05-08 | |||
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-07 | $52.00K derived: sum of 2 quarters · filed 2026-08-07 | $72.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $22.00K 10-Q · filed 2026-08-07 | $42.00K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-08 | |||
| 2024-09-30 | $233.00K 10-Q · filed 2025-11-07 | $279.00K derived: sum of 2 quarters · filed 2025-11-07 | $437.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $46.00K 10-Q · filed 2025-08-08 | $204.00K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $158.00K 10-Q · filed 2025-05-09 | |||
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $368.00K 10-Q · filed 2023-11-09 | $1.51M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-04 | $369.00K 10-Q · filed 2023-08-04 | $1.51M derived: sum of 3 quarters · filed 2023-08-04 | $1.51M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $368.00K 10-Q · filed 2023-05-10 | $1.51M derived: sum of 2 quarters · filed 2023-05-10 | $1.51M derived: sum of 3 quarters · filed 2023-05-10 | $1.89M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.14M derived: sum of 2 quarters · filed 2022-11-09 | $1.52M derived: sum of 3 quarters · filed 2022-11-09 | $1.64M 10-K · filed 2022-02-25 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $385.00K derived: sum of 2 quarters · filed 2022-11-09 | $495.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $385.00K 10-Q · filed 2022-08-05 | $495.00K 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $110.00K 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |